← Leaderboards
Chunwan Lu
Chemedimmune, Inc.
$202,500
Attributed
$202,500
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$202,500 · 1
By mechanism
R43$202,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Chemedimmune, Inc.
Same institution · by research overlap
- Priscilla Simon Redd$650,207
Others in their field
Other Emerging Leaders on “Analog”
- John Hobbs · Suny At Stony Brook$41,239,084
- Christopher Bee · Suny At Stony Brook$41,239,084
- John Damon Chodera · Sloan-Kettering Inst Can Research$15,023,002
- Jeffrey Reich · Sparian Biosciences, Inc.$14,845,721
- Thomas Dick · Rbhs-New Jersey Medical School$14,469,725
- Terry Roemer · Prokaryotics, Inc.$14,198,753
Research focus
AnalogAnti-CancerAnti-Pd-1Anti-Pd1 AntibodiesAnti-Pd1 TherapyAnti-Pd-L1ApoptosisBaseCancer CellCancer ImmunotherapyCancer PatientCancer TherapyCasp8 GeneCd95 AntigensCell DeathCell PhysiologyCellsCeramidesCessation Of LifeChemotherapeutic AgentColon CarcinomaColorectal CancerCytotoxic T-LymphocytesAffinity